Changes in serotonin dynamics in the gastrointestinal tract of Colon-26 tumour-bearing mice: Effects of cisplatin treatment

Y. Nitta, Masahiro Nishibori, H. Iwagaki, Tadashi Yoshino, S. Mori, K. Sawada, N. Nakaya, K. Saeki, N. Tanaka

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Severe nausea and vomiting are common side effects of anti-cancer chemotherapy. 5-HT3 receptor antagonists have been used for the treatment of these gastrointestinal symptoms. The purpose of this study was to examine whether specific changes in serotonin dynamics occurred in the gastrointestinal tract in mice in which Colon-26 adenocarcinoma cells were injected s.c., especially after treatment with cisplatin. The serotonin content of the small intestine of mice inoculated s.c. with Colon-26 adenocarcinoma increased significantly 2 weeks after the inoculation of the tumor cells; this was associated with an increase in tryptophan hydroxylase activity and the number of enterochromaffin cells as compared with control mice. Intravenous injection of cisplatin significantly reduced the serotonin content in the small intestine of Colon-26 tumour-bearing mice but not in control mice. The spontaneous release of serotonin from isolated intestine was not different between Colon-26 tumour-bearing and control mice; however, pretreatment of mice with cisplatin induced two fold increases in serotonin release from duodenum, jejunum and ileum in Colon-26 tumour-bearing mice but not in control mice. These results indicate that a region-specific increase in the number of enterochromaffin cells is observed in the intestine of Colon-26 tumour-bearing mice, associated with an increase in the serotonin content and tryptophan hydroxylase activity. Cisplatin treatment induced the release of serotonin from affected enterochromaffin cells in the gastrointestinal tract, which may be related to the occurrence of nausea in clinical use.

Original languageEnglish
Pages (from-to)329-334
Number of pages6
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume364
Issue number4
DOIs
Publication statusPublished - 2001

Fingerprint

Cisplatin
Gastrointestinal Tract
Serotonin
Colon
Enterochromaffin Cells
Neoplasms
Tryptophan Hydroxylase
Therapeutics
Nausea
Small Intestine
Intestines
Adenocarcinoma
Serotonin 5-HT3 Receptor Antagonists
Receptors, Serotonin, 5-HT3
Jejunum
Ileum
Duodenum
Intravenous Injections
Vomiting
Drug Therapy

Keywords

  • Cisplatin
  • Enterochromaffin cell
  • Intestine
  • Serotonin
  • Stomach
  • Tumour-bearing mice

ASJC Scopus subject areas

  • Pharmacology

Cite this

Changes in serotonin dynamics in the gastrointestinal tract of Colon-26 tumour-bearing mice : Effects of cisplatin treatment. / Nitta, Y.; Nishibori, Masahiro; Iwagaki, H.; Yoshino, Tadashi; Mori, S.; Sawada, K.; Nakaya, N.; Saeki, K.; Tanaka, N.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 364, No. 4, 2001, p. 329-334.

Research output: Contribution to journalArticle

@article{64eebbf4713d4107a10f8ee6fc3df524,
title = "Changes in serotonin dynamics in the gastrointestinal tract of Colon-26 tumour-bearing mice: Effects of cisplatin treatment",
abstract = "Severe nausea and vomiting are common side effects of anti-cancer chemotherapy. 5-HT3 receptor antagonists have been used for the treatment of these gastrointestinal symptoms. The purpose of this study was to examine whether specific changes in serotonin dynamics occurred in the gastrointestinal tract in mice in which Colon-26 adenocarcinoma cells were injected s.c., especially after treatment with cisplatin. The serotonin content of the small intestine of mice inoculated s.c. with Colon-26 adenocarcinoma increased significantly 2 weeks after the inoculation of the tumor cells; this was associated with an increase in tryptophan hydroxylase activity and the number of enterochromaffin cells as compared with control mice. Intravenous injection of cisplatin significantly reduced the serotonin content in the small intestine of Colon-26 tumour-bearing mice but not in control mice. The spontaneous release of serotonin from isolated intestine was not different between Colon-26 tumour-bearing and control mice; however, pretreatment of mice with cisplatin induced two fold increases in serotonin release from duodenum, jejunum and ileum in Colon-26 tumour-bearing mice but not in control mice. These results indicate that a region-specific increase in the number of enterochromaffin cells is observed in the intestine of Colon-26 tumour-bearing mice, associated with an increase in the serotonin content and tryptophan hydroxylase activity. Cisplatin treatment induced the release of serotonin from affected enterochromaffin cells in the gastrointestinal tract, which may be related to the occurrence of nausea in clinical use.",
keywords = "Cisplatin, Enterochromaffin cell, Intestine, Serotonin, Stomach, Tumour-bearing mice",
author = "Y. Nitta and Masahiro Nishibori and H. Iwagaki and Tadashi Yoshino and S. Mori and K. Sawada and N. Nakaya and K. Saeki and N. Tanaka",
year = "2001",
doi = "10.1007/s002100100461",
language = "English",
volume = "364",
pages = "329--334",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Changes in serotonin dynamics in the gastrointestinal tract of Colon-26 tumour-bearing mice

T2 - Effects of cisplatin treatment

AU - Nitta, Y.

AU - Nishibori, Masahiro

AU - Iwagaki, H.

AU - Yoshino, Tadashi

AU - Mori, S.

AU - Sawada, K.

AU - Nakaya, N.

AU - Saeki, K.

AU - Tanaka, N.

PY - 2001

Y1 - 2001

N2 - Severe nausea and vomiting are common side effects of anti-cancer chemotherapy. 5-HT3 receptor antagonists have been used for the treatment of these gastrointestinal symptoms. The purpose of this study was to examine whether specific changes in serotonin dynamics occurred in the gastrointestinal tract in mice in which Colon-26 adenocarcinoma cells were injected s.c., especially after treatment with cisplatin. The serotonin content of the small intestine of mice inoculated s.c. with Colon-26 adenocarcinoma increased significantly 2 weeks after the inoculation of the tumor cells; this was associated with an increase in tryptophan hydroxylase activity and the number of enterochromaffin cells as compared with control mice. Intravenous injection of cisplatin significantly reduced the serotonin content in the small intestine of Colon-26 tumour-bearing mice but not in control mice. The spontaneous release of serotonin from isolated intestine was not different between Colon-26 tumour-bearing and control mice; however, pretreatment of mice with cisplatin induced two fold increases in serotonin release from duodenum, jejunum and ileum in Colon-26 tumour-bearing mice but not in control mice. These results indicate that a region-specific increase in the number of enterochromaffin cells is observed in the intestine of Colon-26 tumour-bearing mice, associated with an increase in the serotonin content and tryptophan hydroxylase activity. Cisplatin treatment induced the release of serotonin from affected enterochromaffin cells in the gastrointestinal tract, which may be related to the occurrence of nausea in clinical use.

AB - Severe nausea and vomiting are common side effects of anti-cancer chemotherapy. 5-HT3 receptor antagonists have been used for the treatment of these gastrointestinal symptoms. The purpose of this study was to examine whether specific changes in serotonin dynamics occurred in the gastrointestinal tract in mice in which Colon-26 adenocarcinoma cells were injected s.c., especially after treatment with cisplatin. The serotonin content of the small intestine of mice inoculated s.c. with Colon-26 adenocarcinoma increased significantly 2 weeks after the inoculation of the tumor cells; this was associated with an increase in tryptophan hydroxylase activity and the number of enterochromaffin cells as compared with control mice. Intravenous injection of cisplatin significantly reduced the serotonin content in the small intestine of Colon-26 tumour-bearing mice but not in control mice. The spontaneous release of serotonin from isolated intestine was not different between Colon-26 tumour-bearing and control mice; however, pretreatment of mice with cisplatin induced two fold increases in serotonin release from duodenum, jejunum and ileum in Colon-26 tumour-bearing mice but not in control mice. These results indicate that a region-specific increase in the number of enterochromaffin cells is observed in the intestine of Colon-26 tumour-bearing mice, associated with an increase in the serotonin content and tryptophan hydroxylase activity. Cisplatin treatment induced the release of serotonin from affected enterochromaffin cells in the gastrointestinal tract, which may be related to the occurrence of nausea in clinical use.

KW - Cisplatin

KW - Enterochromaffin cell

KW - Intestine

KW - Serotonin

KW - Stomach

KW - Tumour-bearing mice

UR - http://www.scopus.com/inward/record.url?scp=0034788884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034788884&partnerID=8YFLogxK

U2 - 10.1007/s002100100461

DO - 10.1007/s002100100461

M3 - Article

C2 - 11683520

AN - SCOPUS:0034788884

VL - 364

SP - 329

EP - 334

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 4

ER -